Prevention and early treatment of mild covid cases have been identified by the IATF as crucial in preventing the cases into escalating into moderate and severe cases thus prevent over- burdening the country's healthcare system.
Cabinet Secretary Karlo Nograles co-chairperson of the IATF turns over Cocolicious VCO to Army Col. Jonna D. Dalaguit (MAC) GSC PA Commanding Officer of Army General Hospital and to Maj. Ali B. Saripada, Logisitc Officer, AGH in Taguig City for its covid isolation and quarantine facilities for army personnel and their dependents.
Cocolicious CEO Reynaldo Pacheco shared to Col. Dalaguit, a pediatrician by medical training, the health benefits of VCO as "contra covid" supplemental treatment and the simple ways to use VCO such as mixing in meals, drinking 1 tablespoon during meals, oil pulling (as mouthwash 1tbsp for 10 mins), applying to the nostrils, and rubbing to the skin armpits and neck.
Pacheco also cited the recent DOST-FNRI VCO Clinical study which proves that VCO is effective on mild covid cases as "anti-infection and anti-inflammatory" as shown by the drop in C-Reactive Protein (CRP) to within normal levels of the patients in the DOST study. Clinical trials for moderate and severe cases are underway in the PGH.
Cocolicious together with the VCOP, the VCO association of producers and traders, has partnered with the IATF to distribute Cocolicious VCO to level 1 hospitals and community isolation facilities.
NOTE: COCOLICIOUS IS A DIETARY SUPPLEMENT APPROVED BY THE FDA. IT IS NOT A DRUG AND SHOULD NOT BE USED AS A DRUG TO TREAT ANY DISEASE.